BACKGROUND: Human metapneumovirus (HMPV) is a paramyxovirus with multiple genetic lineages that is a leading cause of acute respiratory disease. Several RT-PCR assays have been described based on limited available sequence data. OBJECTIVES: To develop a broadly reactive real-time RT-PCR assay for HMPV that allows for a rapid, sensitive, and specific detection in a clinical or research setting. STUDY DESIGN: Three published assays for HMPV were modified based on analysis of multiple HMPV sequences obtained from GenBank. Original and modified assays were tested against prototype HMPV strains from each genetic sublineage, multiple isolates of HMPV from different years, a collection of clinical specimens, and commercial validation panels. RESULTS: A number of potential sequence mismatches with diverse HMPV strains were identified. Modifications were made to oligonucleotides to improve annealing efficiency. Primers and probes based on newer sequence data offered enhanced detection of all subgroups, especially for low titer specimens. The new primers and probe detected multiple clinical isolates of HMPV collected over a twenty-year period. The modified assay improved detection of HMPV in a panel of clinical specimens, and correctly identified HMPV samples in two commercial validation sets. CONCLUSIONS: We report a modified real-time RT-PCR assay for HMPV that detects all genetic lineages with high sensitivity.
BACKGROUND:Human metapneumovirus (HMPV) is a paramyxovirus with multiple genetic lineages that is a leading cause of acute respiratory disease. Several RT-PCR assays have been described based on limited available sequence data. OBJECTIVES: To develop a broadly reactive real-time RT-PCR assay for HMPV that allows for a rapid, sensitive, and specific detection in a clinical or research setting. STUDY DESIGN: Three published assays for HMPV were modified based on analysis of multiple HMPV sequences obtained from GenBank. Original and modified assays were tested against prototype HMPV strains from each genetic sublineage, multiple isolates of HMPV from different years, a collection of clinical specimens, and commercial validation panels. RESULTS: A number of potential sequence mismatches with diverse HMPV strains were identified. Modifications were made to oligonucleotides to improve annealing efficiency. Primers and probes based on newer sequence data offered enhanced detection of all subgroups, especially for low titer specimens. The new primers and probe detected multiple clinical isolates of HMPV collected over a twenty-year period. The modified assay improved detection of HMPV in a panel of clinical specimens, and correctly identified HMPV samples in two commercial validation sets. CONCLUSIONS: We report a modified real-time RT-PCR assay for HMPV that detects all genetic lineages with high sensitivity.
Authors: Jeroen Maertzdorf; Chiaoyin K Wang; Jennifer B Brown; Joseph D Quinto; Marla Chu; Miranda de Graaf; Bernadette G van den Hoogen; Richard Spaete; Albert D M E Osterhaus; Ron A M Fouchier Journal: J Clin Microbiol Date: 2004-03 Impact factor: 5.948
Authors: Ian M Mackay; Kevin C Jacob; Daniel Woolhouse; Katharine Waller; Melanie W Syrmis; David M Whiley; David J Siebert; Michael Nissen; Theo P Sloots Journal: J Clin Microbiol Date: 2003-01 Impact factor: 5.948
Authors: John V Williams; Paul A Harris; Sharon J Tollefson; Lisa L Halburnt-Rush; Joyce M Pingsterhaus; Kathryn M Edwards; Peter F Wright; James E Crowe Journal: N Engl J Med Date: 2004-01-29 Impact factor: 91.245
Authors: B G van den Hoogen; J C de Jong; J Groen; T Kuiken; R de Groot; R A Fouchier; A D Osterhaus Journal: Nat Med Date: 2001-06 Impact factor: 53.440
Authors: Melissa A Hilmes; F Daniel Dunnavant; Sudha P Singh; Wendy D Ellis; Daniel C Payne; Yuwei Zhu; Marie R Griffin; Kathryn M Edwards; John V Williams Journal: Pediatr Radiol Date: 2017-08-22
Authors: Leigh M Howard; Monika Johnson; John V Williams; Yuwei Zhu; Ana I Gil; Kathryn M Edwards; Marie R Griffin; Claudio F Lanata; Carlos G Grijalva Journal: Pediatr Infect Dis J Date: 2015-10 Impact factor: 2.129
Authors: Carolina Loria; Jennifer A Domm; Natasha B Halasa; Elizabeth Heitman; E Kathryn Miller; Meng Xu; Benjamin R Saville; Haydar Frangoul; John V Williams Journal: Pediatr Transplant Date: 2014-11-06
Authors: E Kathryn Miller; Jodell Linder; David Kraft; Monika Johnson; Pengcheng Lu; Benjamin R Saville; John V Williams; Marie R Griffin; H Keipp Talbot Journal: J Allergy Clin Immunol Date: 2015-08-06 Impact factor: 10.793
Authors: Carlos G Grijalva; Marie R Griffin; Kathryn M Edwards; John V Williams; Ana I Gil; Héctor Verastegui; Stella M Hartinger; Jorge E Vidal; Keith P Klugman; Claudio F Lanata Journal: Int J Epidemiol Date: 2013-06-14 Impact factor: 7.196
Authors: John T Bates; Jennifer A Pickens; Jennifer E Schuster; Monika Johnson; Sharon J Tollefson; John V Williams; Nancy L Davis; Robert E Johnston; Nancy Schultz-Darken; James C Slaughter; Frances Smith-House; James E Crowe Journal: Vaccine Date: 2016-01-07 Impact factor: 3.641
Authors: Carlos G Grijalva; Marie R Griffin; Kathryn M Edwards; Monika Johnson; Ana I Gil; Héctor Verástegui; Claudio F Lanata; John V Williams Journal: J Clin Virol Date: 2014-04-29 Impact factor: 3.168
Authors: E Kathryn Miller; Tebeb Gebretsadik; Kecia N Carroll; William D Dupont; Yassir A Mohamed; Laura-Lee Morin; Luke Heil; Patricia A Minton; Kimberly Woodward; Zhouwen Liu; Tina V Hartert; John V Williams Journal: Pediatr Infect Dis J Date: 2013-09 Impact factor: 2.129
Authors: Philip J Budge; Marie R Griffin; Kathryn M Edwards; John V Williams; Hector Verastegui; Stella M Hartinger; Monika Johnson; Jennifer M Klemenc; Yuwei Zhu; Ana I Gil; Claudio F Lanata; Carlos G Grijalva Journal: Pediatr Infect Dis J Date: 2014-05 Impact factor: 2.129